News

Published on 2 Apr 2024 on Simply Wall St. via Yahoo Finance

CSL Limited (ASX:CSL) On An Uptrend: Could Fundamentals Be Driving The Stock?


Article preview image

CSL's (ASX:CSL) stock is up by 1.2% over the past month. We wonder if and what role the company's financials play in that price change as a company's long-term fundamentals usually dictate market outcomes. In this article, we decided to focus on CSL's ROE.

ROE or return on equity is a useful tool to assess how effectively a company can generate returns on the investment it received from its shareholders. In simpler terms, it measures the profitability of a company in relation to shareholder's equity.

See our latest analysis for CSL

ASX.ASX price evolution
ASX price evolution
ASX.CSL price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Carlisle to Boost Product Portfolio With the Acquisition of ThermaFoam

Carlisle Companies Incorporated CSL recently announced that it has signed a definitive deal to...

Zacks · via Yahoo Finance 24 Dec 2024

Carlisle Buys Plasti-Fab & Enhances its Position in Polystyrene Market

Carlisle Companies Incorporated CSL recently completed the acquisition of the expanded polystyren...

Zacks · via Yahoo Finance 19 Dec 2024

Is It Too Late To Consider Buying Carlisle Companies Incorporated (NYSE:CSL)?

Carlisle Companies Incorporated (NYSE:CSL) saw a double-digit share price rise of over 10% in the...

Simply Wall St. · via Yahoo Finance 8 Dec 2024

EXEL vs. CSLLY: Which Stock Is the Better Value Option?

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Exelixi...

Zacks · via Yahoo Finance 21 Nov 2024

Decoding Carlisle Companies Inc (CSL): A Strategic SWOT Insight

Robust Revenue Growth: CSL reports a significant increase in revenues, marking a strong financial...

GuruFocus.com · via Yahoo Finance 26 Oct 2024

GSK, Sanofi, And CSL Secure US Government Fund To Boost Bird Flu Vaccine...

The U.S. government has granted $72 million to European pharma giants GSK Plc (NYSE:GSK), Sanofi ...

Benzinga · via Yahoo Finance 5 Oct 2024

Arcturus Therapeutics/CSL Partnered COVID-19 Vaccine Surpasses Pfizer's...

Arcturus Therapeutics/CSL Partnered COVID-19 Vaccine Surpasses Pfizer's Comirnaty Shot, Even At L...

Benzinga · via Yahoo Finance 30 Sep 2024

Arcturus Therapeutics/CSL Partnered COVID-19 Vaccine Surpasses Pfizer's...

CSL Limited (OTC:CSLLY) and Arcturus Therapeutics (NASDAQ:ARCT) announced the results of a Phase ...

Benzinga · via AOL 30 Sep 2024

Does Carlisle Companies Incorporated (CSL)’s Strong Financial Performance Make...

We recently compiled a list of the 9 Best Plastics and Rubber Stocks to Buy. In this article, we ...

Insider Monkey · via Yahoo Finance 20 Jun 2024

Here's Why You Should Add Carlisle (CSL) to Your Portfolio

Carlisle Companies Incorporated CSL is well poised for growth, courtesy of strength across its bu...

Zacks via Yahoo Finance 31 May 2024